25197640|t|Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
25197640|a|Parkinson's disease (PD) is a major neurodegenerative disorder for which the etiology and pathogenesis remain as elusive as for Alzheimer's disease. PD appears to be caused by genetic and environmental factors, and pedigree and cohort studies have identified numerous susceptibility genes and loci related to PD. Autosomal recessive mutations in the genes Parkin, Pink1, DJ-1, ATP13A2, PLA2G6, and FBXO7 have been linked to PD susceptibility. Such mutations in ATP13A2, also named PARK9, were first identified in 2006 in a Chilean family and are associated with a juvenile-onset, levodopa-responsive type of Parkinsonism called Kufor-Rakeb syndrome (KRS). KRS involves pyramidal degeneration, supranuclear palsy, and cognitive impairment. Here we review current knowledge about the ATP13A2 gene, clinical characteristics of patients with PD-associated ATP13A2 mutations, and models of how the ATP13A2 protein may help prevent neurodegeneration by inhibiting alpha-synuclein aggregation and supporting normal lysosomal and mitochondrial function. We also discuss another ATP13A2 mutation that is associated with the family of neurodegenerative disorders called neuronal ceroid lipofuscinoses (NCLs), and we propose a single pathway whereby ATP13A2 mutations may contribute to NCLs and Parkinsonism. Finally, we highlight how studies of mutations in this gene may provide new insights into PD pathogenesis and identify potential therapeutic targets. 
25197640	17	24	ATP13A2	Gene	23400
25197640	34	46	Parkinsonism	Disease	MESH:D010302
25197640	70	89	Parkinson's disease	Disease	MESH:D010300
25197640	91	93	PD	Disease	MESH:D010300
25197640	106	132	neurodegenerative disorder	Disease	MESH:D019636
25197640	198	217	Alzheimer's disease	Disease	MESH:D000544
25197640	219	221	PD	Disease	MESH:D010300
25197640	379	381	PD	Disease	MESH:D010300
25197640	426	432	Parkin	Gene	5071
25197640	434	439	Pink1	Gene	65018
25197640	441	445	DJ-1	Gene	11315
25197640	447	454	ATP13A2	Gene	23400
25197640	456	462	PLA2G6	Gene	8398
25197640	468	473	FBXO7	Gene	25793
25197640	494	496	PD	Disease	MESH:D010300
25197640	531	538	ATP13A2	Gene	23400
25197640	551	556	PARK9	Gene	23400
25197640	650	658	levodopa	Chemical	MESH:D007980
25197640	678	690	Parkinsonism	Disease	MESH:D010302
25197640	698	718	Kufor-Rakeb syndrome	Disease	MESH:C537177
25197640	720	723	KRS	Disease	MESH:C537177
25197640	726	729	KRS	Disease	MESH:C537177
25197640	739	761	pyramidal degeneration	Disease	MESH:C531847
25197640	763	781	supranuclear palsy	Disease	MESH:D013494
25197640	787	807	cognitive impairment	Disease	MESH:D003072
25197640	852	859	ATP13A2	Gene	23400
25197640	894	902	patients	Species	9606
25197640	908	910	PD	Disease	MESH:D010300
25197640	922	929	ATP13A2	Gene	23400
25197640	963	970	ATP13A2	Gene	23400
25197640	996	1013	neurodegeneration	Disease	MESH:D019636
25197640	1028	1043	alpha-synuclein	Gene	6622
25197640	1140	1147	ATP13A2	Gene	23400
25197640	1195	1222	neurodegenerative disorders	Disease	MESH:D019636
25197640	1230	1260	neuronal ceroid lipofuscinoses	Disease	MESH:D009472
25197640	1262	1266	NCLs	Disease	MESH:D009472
25197640	1309	1316	ATP13A2	Gene	23400
25197640	1345	1349	NCLs	Disease	MESH:D009472
25197640	1354	1366	Parkinsonism	Disease	MESH:D010302
25197640	1458	1460	PD	Disease	MESH:D010300
25197640	Association	MESH:D010300	5071
25197640	Association	MESH:D010300	65018
25197640	Negative_Correlation	MESH:D007980	MESH:C537177
25197640	Association	MESH:D009472	23400
25197640	Association	MESH:D013494	23400
25197640	Association	MESH:D010302	23400
25197640	Association	MESH:D010300	8398
25197640	Association	MESH:C537177	23400
25197640	Association	MESH:D010300	23400
25197640	Association	MESH:D003072	23400
25197640	Association	MESH:D010300	11315
25197640	Negative_Correlation	MESH:D007980	MESH:D010302
25197640	Association	MESH:D010300	25793
25197640	Association	MESH:D019636	23400
25197640	Negative_Correlation	23400	6622

